| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4004629 | American Journal of Ophthalmology | 2009 | 6 Pages |
Abstract
This study showed that the response of macular cysts to dorzolamide in patients with XLRS may be observed independent of the mechanism responsible for retinoschisin protein dysfunction. Hence, treatment with dorzolamide may be effective in patients with different mechanisms of dysfunction in retinoschisin.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Saloni Walia, Gerald A. Fishman, Robert S. Molday, Frank M. Dyka, Nalin M. Kumar, Mary A. Ehlinger, Edwin M. Stone,